학술논문
Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysis
Document Type
Article
Author
Source
In Heliyon 15 May 2024 10(9)
Subject
Language
ISSN
2405-8440